24 results
8-K
EX-10.1
XLO
Xilio Therapeutics Inc
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants
8-K
EX-99.2
th9ir51fgswm
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am
8-K
EX-99.1
trld9w7kl65yjwnzd9wf
25 May 23
Regulation FD Disclosure
5:05pm
S-3
EX-1.2
1e0pqe1iqmoxqml68
9 Nov 22
Shelf registration
4:15pm
8-K
EX-99.2
5umqg cr6ov09
9 Nov 22
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results
7:45am
8-K
EX-99.2
qsx0bcj
12 May 22
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
7:36am
10-K
0k4p7fitga6uet10l
1 Mar 22
Annual report
4:07pm
10-Q
vw0l40av7xgr3i1r0
2 Dec 21
Quarterly report
4:15pm
424B4
p5rm5s nux7m
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
1qmygupjeiyie 2kqj
18 Oct 21
IPO registration (amended)
6:04am
S-1/A
EX-1.1
bh55vnvr686rr 5lzn
18 Oct 21
IPO registration (amended)
6:04am
S-1
EX-10.14
9kggy qt5vi
1 Oct 21
IPO registration
4:49pm